Status:

COMPLETED

Efficacy of Ultrasound to Guide Management During a Rapid Response Event

Lead Sponsor:

Beth Israel Medical Center

Conditions:

Hemodynamic Instability

Respiratory Failure

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Rapid response team systems have been implemented in numerous hospitals throughout the world with the goal of improving the identification and safety of hospitalized patients who are clinically deteri...

Detailed Description

This is an randomized controlled trial to determine if portable critical care ultrasound use is feasible, if its findings change clinical decision making by critical care fellows and whether ultrasoun...

Eligibility Criteria

Inclusion

  • Patients for whom a rapid response is called who have:
  • Hemodynamic instability as defined by:
  • Systolic blood pressure less than 90 mmHg or less than 40 mmHg from previously established baseline
  • Heart rate greater than 130 beats per minute
  • Known elevated lactate above normal value.
  • Hypercapnic or hypoxemic respiratory failure as judged by the responding critical care fellow.

Exclusion

  • Patients for whom a rapid response has been called who:
  • Are not hemodynamically unstable and not in respiratory failure.
  • Are hemodynamically unstable but who have an obvious source of bleeding to explain hemodynamic instability.

Key Trial Info

Start Date :

March 1 2013

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

March 1 2014

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT01838343

Start Date

March 1 2013

End Date

March 1 2014

Last Update

December 31 2014

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Beth Israel Medical Center

New York, New York, United States, 10003